Publication: Prevalence and incidence of major depressive disorders among people living with HIV residing in Africa: a systematic review and meta-analysis protocol
Open/View Files
Date
2018
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
BioMed Central
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Bigna, Jean Joel, Lewis N. Um, Serra Lem Asangbeh, Aurelie T. Sibetcheu, Arnaud D. Kazé, and Jobert Richie Nansseu. 2018. “Prevalence and incidence of major depressive disorders among people living with HIV residing in Africa: a systematic review and meta-analysis protocol.” Systematic Reviews 7 (1): 6. doi:10.1186/s13643-018-0672-2. http://dx.doi.org/10.1186/s13643-018-0672-2.
Research Data
Abstract
Background: Depression represents one of the most frequent neuro-psychiatric diseases; it seems to be more prevalent in people living with HIV compared to the general population. However, summarized data in the African setting on the topic are scarce. This systematic review and meta-analysis aims at assessing the prevalence and incidence of major depressive disorders (MDD) in HIV-infected African populations residing in Africa. Methods and design This review will include observational studies conducted among HIV-infected people residing in Africa, which have reported either the prevalence or incidence of MDD or enough data for its appraisal. Relevant records will be searched using PubMed/Medline, EMBASE, African Journals Online, and Africa Index Medicus. In addition, reference lists of eligible papers and relevant review articles will be screened. Published studies from inception Jan 1, 2000 to Dec 31, 2017 will be considered regardless of language of publication. Two review authors will independently screen, select studies, and extract data, with discrepancies resolved by consensus or arbitration by a third review author. Methodological quality of included studies will be assessed using the scale developed by Hoy and colleagues. Funnel-plots and Egger’s test will be used to determine publication bias. The study-specific estimates will be pooled through a random-effects meta-analysis model to obtain an overall summary estimate. The heterogeneity will be evaluated by the χ2 test on Cochrane’s Q statistic. Results will be presented by geographical region and antiretroviral therapy status. Discussion This study is based on published data; therefore, ethical approval is not a requirement. The final report of this study in the form of a scientific paper will be published in a peer-reviewed journal and presented at scientific conferences. This review will help to have an overview of the burden of MDD among HIV-infected people residing in Africa. Systematic review registration PROSPERO, CRD42017058118. Electronic supplementary material The online version of this article (10.1186/s13643-018-0672-2) contains supplementary material, which is available to authorized users.
Description
Other Available Sources
Keywords
Depression, HIV, AIDS, Major depressive disorders, Epidemiology, Prevalence, Incidence, Risk factors
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service